Outbred mice as an appropriate model for evaluating the immunogenicity of vaccines against porcine circovirus 2
Vitor Barbosa Fialho Martins, Guilherme de Brito Viana, Emylli Teles de Melo Zocarato, Karen Ferraz Faria, Marina Caporusso Garcia da Silva, Taís Fukuta da Cruz, Igor Renan Honorato Gatto, Marcus Antonio Martins Buso, Ferdinando Nielsen de Almeida, Hélio José Montassier · 2026
Read Outbred mice as an appropriate model for evaluating the immunogenicity of vaccines against porcine circovirus 2 by Vitor Barbosa Fialho Martins, Guilherme de Brito Viana, Emylli Teles de Melo Zocarato, Karen Ferraz Faria, Marina Caporusso Garcia da Silva, Taís Fukuta da Cruz, Igor Renan Honorato Gatto, Marcus Antonio Martins Buso, Ferdinando Nielsen de Almeida, Hélio José Montassier (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13314108.txt.
Description
Vitor Barbosa Fialho Martins and colleagues ask, in a 2026 study, whether genetically mixed Swiss mice can judge pig vaccine quality as well as standard laboratory strains. Porcine circovirus 2 causes heavy losses in swine production, and vaccine testing usually relies on uniform inbred mice, even though outbred animals better mirror the variety of real immune systems. One hundred eight young female mice from three backgrounds received recombinant vaccines against two virus genotypes or plain water, with doses on days zero and fourteen and antibody measurement at day twenty-eight.
Every vaccinated mouse seroconverted, while all controls stayed negative. Antibody titers ran high across groups, spanning 1:25,600 to 1:102,400 in the reported dilutions, and no statistically significant difference separated outbred Swiss mice from the two inbred strains. The authors conclude that Swiss mice mount responses equivalent to the traditional models and can serve in immunogenicity and quality-control testing for these vaccines.
Catalog record
| CREATOR | Vitor Barbosa Fialho Martins, Guilherme de Brito Viana, Emylli Teles de Melo Zocarato, Karen Ferraz Faria, Marina Caporusso Garcia da Silva, Taís Fukuta da Cruz, Igor Renan Honorato Gatto, Marcus Antonio Martins Buso, Ferdinando Nielsen de Almeida, Hélio José Montassier |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |